Skip to content 
The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation. more
| Time Frame | LFSC | S&P500 |
|---|---|---|
| 1-Week Return | -3.85% | 0.5% |
| 1-Month Return | 1.24% | 3.86% |
| 3-Month Return | 16.56% | 1.92% |
| 6-Month Return | 26.5% | 12.03% |
| 1-Year Return | 64.25% | 18.56% |
| 3-Year Return | 83.83% | 73.83% |
| Stock name | Ticker | Weight |
|---|---|---|
 Travere Therapeutics Inc | TVTX | 8.56% |
 Spyre Therapeutics Inc | SYRE | 6.77% |
 Corcept Therapeutics Inc | CORT | 6.69% |
 Cogent Biosciences Inc | COGT | 6.62% |
 LivaNova PLC | LIVN | 6.4% |
 Mirum Pharmaceuticals Inc | MIRM | 4.24% |
 Billiontoone Inc | BLLN | 3.91% |
 Guardant Health Inc | GH | 3.9% |
 Cytokinetics Inc | CYTK | 3.7% |
 United Therapeutics Corp | UTHR | 3.27% |
 Axsome Therapeutics Inc | AXSM | 3.06% |
 TransMedics Group Inc | TMDX | 3.04% |
 Nektar Therapeutics | NKTR | 2.99% |
 VeraDermics Inc | MANE | 2.86% |
 Savara Inc | SVRA | 2.82% |
 Dianthus Therapeutics Inc | DNTH | 2.75% |
 ICU Medical Inc | ICUI | 2.7% |
 Trevi Therapeutics Inc | TRVI | 2.7% |
 Viridian Therapeutics Inc | VRDN | 2.51% |
 Twist Bioscience Corp | TWST | 2.16% |
 Palvella Therapeutics Inc | PVLA | 2.05% |
 Corvus Pharmaceuticals Inc | CRVS | 1.92% |
 Ceribell Inc | CBLL | 1.63% |
 Hinge Health Inc | HNGE | 1.29% |
 NeoGenomics Inc | NEO | 1.22% |
 Aveanna Healthcare Holdings Inc | AVAH | 1.15% |
 Waystar Holding Corp | WAY | 1.1% |
 Alphatec Holdings Inc | ATEC | 1.09% |
 Globus Medical Inc | GMED | 1.06% |
 Praxis Precision Medicines Inc | PRAX | 1% |
 RadNet Inc | RDNT | 0.89% |
 Lumexa Imaging Holdings Inc | LMRI | 0.88% |
 Korro Bio Inc | KRRO | 0.66% |
 Wave Life Sciences Inc | WVE | 0.62% |
 Insmed Inc | INSM | 0.58% |
 Replimune Group Inc | REPL | 0.54% |
 F/m Ultrashort Treasury Inflation-Protected Security TIPS ETF | RBIL | 0.43% |
 Alamar Biosciences Inc | ALMR | 0.25% |
 U.S. Bank Money Market Deposit Account 08/01/2031 | U.S..Bank.Money.Market.Deposit.Account.08.01.2031 | 0% |
 Cash & Other | Cash...Other | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
F/m Emerald Life Sciences Innovation ETF (LFSC) share price today is $45.555.
Yes, Indians can buy shares of F/m Emerald Life Sciences Innovation ETF (LFSC) on Vested. To buy LFSC from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of F/m Emerald Life Sciences Innovation ETF (LFSC) on Vested. You can start investing in F/m Emerald Life Sciences Innovation ETF (LFSC) with a minimum investment of $1.
The 52-week high price of F/m Emerald Life Sciences Innovation ETF (LFSC) is $48.78. The 52-week low price of F/m Emerald Life Sciences Innovation ETF (LFSC) is $27.67.
The stock symbol (or ticker) of F/m Emerald Life Sciences Innovation ETF is LFSC.
Yes, you can setup SIP in F/m Emerald Life Sciences Innovation ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of LFSC on the Vested app.
The expense ratio of F/m Emerald Life Sciences Innovation ETF (LFSC) is .
Link copied 
